BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34381363)

  • 1. Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing.
    Chen WY; Evangelista EA; Yang J; Kelly EJ; Yeung CK
    Front Pharmacol; 2021; 12():695920. PubMed ID: 34381363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery.
    Bai J; Wang C
    Front Pharmacol; 2020; 11():407. PubMed ID: 32317971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip.
    Lee HN; Choi YY; Kim JW; Lee YS; Choi JW; Kang T; Kim YK; Chung BG
    Nano Converg; 2021 Nov; 8(1):35. PubMed ID: 34748091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "3Ds" of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening.
    Chambers BE; Weaver NE; Wingert RA
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
    Wright CB; Becker SM; Low LA; Tagle DA; Sieving PA
    J Ocul Pharmacol Ther; 2020; 36(1):25-29. PubMed ID: 31166829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Organ-on-a-Chip Microphysiological Systems to Model Musculoskeletal Pathologies and Accelerate Therapeutic Discovery.
    Ajalik RE; Alenchery RG; Cognetti JS; Zhang VZ; McGrath JL; Miller BL; Awad HA
    Front Bioeng Biotechnol; 2022; 10():846230. PubMed ID: 35360391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D organ-on-a-chip: The convergence of microphysiological systems and organoids.
    Baptista LS; Porrini C; Kronemberger GS; Kelly DJ; Perrault CM
    Front Cell Dev Biol; 2022; 10():1043117. PubMed ID: 36478741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids.
    Oishi H; Tabibzadeh N; Morizane R
    Biofabrication; 2024 Apr; 16(3):. PubMed ID: 38547531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging In Vitro Systems to Screen and Predict Drug-Induced Kidney Toxicity.
    Nieskens TTG; Sjögren AK
    Semin Nephrol; 2019 Mar; 39(2):215-226. PubMed ID: 30827343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human reconstructed kidney models.
    Kishi S; Matsumoto T; Ichimura T; Brooks CR
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):133-147. PubMed ID: 33594607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D kidney organoids for bench-to-bedside translation.
    Gupta N; Dilmen E; Morizane R
    J Mol Med (Berl); 2021 Apr; 99(4):477-487. PubMed ID: 33034708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and medical applications of a brain-on-a-chip.
    Pamies D; Hartung T; Hogberg HT
    Exp Biol Med (Maywood); 2014 Sep; 239(9):1096-1107. PubMed ID: 24912505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney microphysiological models for nephrotoxicity assessment.
    Mahadeo A; Yeung CK; Himmelfarb J; Kelly EJ
    Curr Opin Toxicol; 2022 Jun; 30():. PubMed ID: 35495549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Synthetic Hydrogel, VitroGel
    Cherne MD; Sidar B; Sebrell TA; Sanchez HS; Heaton K; Kassama FJ; Roe MM; Gentry AB; Chang CB; Walk ST; Jutila M; Wilking JN; Bimczok D
    Front Pharmacol; 2021; 12():707891. PubMed ID: 34552484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and Targeting Alzheimer's Disease With Organoids.
    Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA
    Front Pharmacol; 2020; 11():396. PubMed ID: 32300301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in therapeutic development: kidney organoids and organs on a chip.
    Tabibzadeh N; Morizane R
    Kidney Int; 2024 Apr; 105(4):702-708. PubMed ID: 38296026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney organoids: Research in developmental biology and emerging applications.
    Shimizu T; Yamagata K; Osafune K
    Dev Growth Differ; 2021 Feb; 63(2):166-177. PubMed ID: 33569792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an adult stem cell derived microphysiological intestinal system for predicting oral prodrug bioconversion and permeability in humans.
    Sharma A; Jin L; Wang X; Wang YT; Stresser DM
    Lab Chip; 2024 Jan; 24(2):339-355. PubMed ID: 38099395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.